Our data suggest that PFAS exposure has a synergy with an HFD to activate PPARα altering the cell metabolome, which shifts carcinogenic risk in normal cells while driving cancer progression in prostate cancer cells. The gene discussed is PPARA; the disease is Familial prostate cancer.